The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii
Open accessAbstract
Acinetobacter baumannii is a nosocomial pathogen that has emerged as a global threat because of high levels of resistance to many antibiotics, particularly those considered to be last-resort antibiotics, such as carbapenems. Although alterations in the efflux pump and outer membrane proteins can cause carbapenem resistance, the main mechanism is the acquisition of carbapenem-hydrolyzing oxacillinase-encoding genes. Of these, oxa23 is by far the most widespread in most countries, while oxa24 and oxa58 appear to be dominant in specific regions. Historically, much of the global spread of carbapenem resistance has been due to the dissemination of two major clones, known as global clones 1 and 2, although new lineages are now common in some parts of the world. The analysis of all publicly available genome sequences performed here indicates that ST2, ST1, ST79 and ST25 account for over 71 % of all genomes sequenced to date, with ST2 by far the most dominant type and oxa23 the most widespread carbapenem resistance determinant globally, regardless of clonal type. Whilst this highlights the global spread of ST1 and ST2, and the dominance of oxa23 in both clones, it could also be a result of preferential selection of carbapenem-resistant strains, which mainly belong to the two major clones. Furthermore, ~70 % of the sequenced strains have been isolated from five countries, namely the USA, PR China, Australia, Thailand and Pakistan, with only a limited number from other countries. These genomes are a vital resource, but it is currently difficult to draw an accurate global picture of this important superbug, highlighting the need for more comprehensive genome sequence data and genomic analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Mobile Genetic Elements Associated with Antimicrobial Resistance
Partridge, S. R., Kwong, S. M., Firth, N., & Jensen, S. O. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00088-17 · Cited by 2,751
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367 · cited 1×
“Global SpREaD of caRbapENEMRESIStaNt AcinetobActer bAumAnnii Carbapenem antibiotics such as meropenem and imipenem belong to the ß-lactam family and remain active against most ß-lactamase- producing organisms, including those with extended spectrum ß-lactamase enzymes [14].”
BackgroundFederal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1789 · Cited by 1,828
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
Bergogne-Bérézin, E., & Towner, K. J. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.148 · Cited by 1,711
A standard numbering scheme for the class A β-lactamases
Ambler, R. P., Coulson, A. F. W., Frère, J. M., Ghuysen, J. M., Joris, B., Forsman, M., Levesque, R. C., Tiraby, G., & Waley, S. G. (1991) · Biochemical Journal · doi:10.1042/bj2760269 · Cited by 1,073
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
Completing bacterial genome assemblies with multiplex MinION sequencing
Wick, R. R., Judd, L. M., Gorrie, C. L., & Holt, K. E. (2017) · Microbial Genomics · doi:10.1099/mgen.0.000132 · Cited by 978
Acinetobacter baumannii: evolution of a global pathogen
Antunes, L. C. S., Visca, P., & Towner, K. J. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12125 · Cited by 925
Evans, B. A., & Amyes, S. G. B. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-13 · Cited by 815
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
Fournier, P.-E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., Richet, H., Robert, C., Mangenot, S., Abergel, C., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020007 · Cited by 812
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., & Pitt, T. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00195.x · Cited by 751
Carbapenem Resistance: A Review
Codjoe, F., & Donkor, E. (2017) · Medical Sciences · doi:10.3390/medsci6010001 · Cited by 746
Diancourt, L., Passet, V., Nemec, A., Dijkshoorn, L., & Brisse, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010034 · Cited by 719
Diversity, Epidemiology, and Genetics of Class D β-Lactamases
Poirel, L., Naas, T., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01512-08 · Cited by 632
Efflux-Mediated Antibiotic Resistance in Acinetobacter spp
Coyne, S., Courvalin, P., & Périchon, B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01388-10 · Cited by 505
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
Zarrilli, R., Pournaras, S., Giannouli, M., & Tsakris, A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.008 · Cited by 496
Hujer, K. M., Hujer, A. M., Hulten, E. A., Bajaksouzian, S., Adams, J. M., Donskey, C. J., Ecker, D. J., Massire, C., Eshoo, M. W., Sampath, R., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00778-06 · Cited by 480
Smith, M. G., Gianoulis, T. A., Pukatzki, S., Mekalanos, J. J., Ornston, L. N., Gerstein, M., & Snyder, M. (2007) · Genes & Development · doi:10.1101/gad.1510307 · Cited by 474
Whole-Genome Sequencing of Bacterial Pathogens: the Future of Nosocomial Outbreak Analysis
Quainoo, S., Coolen, J. P. M., van Hijum, S. A. F. T., Huynen, M. A., Melchers, W. J. G., van Schaik, W., & Wertheim, H. F. L. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-17 · Cited by 458
Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
Adams, M. D., Goglin, K., Molyneaux, N., Hujer, K. M., Lavender, H., Jamison, J. J., MacDonald, I. J., Martin, K. M., Russo, T., Campagnari, A. A., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.00834-08 · Cited by 435
Worldwide Dissemination of the blaOXA-23Carbapenemase Gene of Acinetobacter baumannii 1
Mugnier, P. D., Poirel, L., Naas, T., & Nordmann, P. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1601.090852 · Cited by 431
Marchand, I., Damier-Piolle, L., Courvalin, P., & Lambert, T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3298-3304.2004 · Cited by 407
Scott, P., Deye, G., Srinivasan, A., Murray, C., Moran, K., Hulten, E., Fishbain, J., Craft, D., Riddell, S., Lindler, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/518170 · Cited by 393
Go, E. S., Urban, C., Burns, J., Mariano, N., Mosinka-Snipas, K., Rahal, J. J., Kreiswirth, B., & Eisner, W. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90694-7 · Cited by 369
Corbella, X., Montero, A., Pujol, M., Domínguez, M. A., Ayats, J., Argerich, M. J., Garrigosa, F., Ariza, J., & Gudiol, F. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.11.4086-4095.2000 · Cited by 348
Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia
Hsu, L.-Y., Apisarnthanarak, A., Khan, E., Suwantarat, N., Ghafur, A., & Tambyah, P. A. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-16 · Cited by 339
Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers
Davis, K. A., Moran, K. A., McAllister, C. K., & Gray, P. J. (2005) · Emerging Infectious Diseases · doi:10.3201/1108.050103 · Cited by 327
Acinetobacter infection – an emerging threat to human health
Visca, P., Seifert, H., & Towner, K. J. (2011) · IUBMB Life · doi:10.1002/iub.534 · Cited by 324
Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options
Murray, G., Peleg, A., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1398388 · Cited by 316
Characterization of the Naturally Occurring Oxacillinase of Acinetobacter baumannii
Héritier, C., Poirel, L., Fournier, P.-E., Claverie, J.-M., Raoult, D., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4174-4179.2005 · Cited by 286
Afzal-Shah, M., Woodford, N., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.583-588.2001 · Cited by 282
Iacono, M., Villa, L., Fortini, D., Bordoni, R., Imperi, F., Bonnal, R. J. P., Sicheritz-Ponten, T., De Bellis, G., Visca, P., Cassone, A., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01643-07 · Cited by 273
Héritier, C., Poirel, L., Lambert, T., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3198-3202.2005 · Cited by 272
Overview: Global and Local Impact of Antibiotic Resistance
Watkins, R. R., & Bonomo, R. A. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.001 · Cited by 258
Naas, T., & Nordmann, P. (1999) · Current Pharmaceutical Design · doi:10.2174/1381612805666230112185101 · Cited by 250
ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii
Paton, R., Miles, R. S., Hood, J., Amyes, S. G. B., Miles, R. S., & Amyes, S. G. B. (1993) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(93)90045-7 · Cited by 245
Characterization and PCR-Based Replicon Typing of Resistance Plasmids in Acinetobacter baumannii
Bertini, A., Poirel, L., Mugnier, P. D., Villa, L., Nordmann, P., & Carattoli, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00542-10 · Cited by 219
Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp
Poirel, L., Figueiredo, S., Cattoir, V., Carattoli, A., & Nordmann, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01304-07 · Cited by 205
Lolans, K., Rice, T. W., Munoz-Price, L. S., & Quinn, J. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00116-06 · Cited by 202
Insights into Acinetobacter baumannii pathogenicity
Cerqueira, G. M., & Peleg, A. Y. (2011) · IUBMB Life · doi:10.1002/iub.533 · Cited by 192
Coelho, J. M., Turton, J. F., Kaufmann, M. E., Glover, J., Woodford, N., Warner, M., Palepou, M.-F., Pike, R., Pitt, T. L., Patel, B. C., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00699-06 · Cited by 191
OXA β-lactamases in Acinetobacter: the story so far
Brown, S., & Amyes, S. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki425 · Cited by 189
Multidrug-resistant Organisms in Military Wounds from Iraq and Afghanistan
Calhoun, J. H., Murray, C. K., & Manring, M. M. (2008) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-008-0212-9 · Cited by 187
(2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.masthead.30-1 · Cited by 184
Naas, T., & Nordmann, P. (1999) · PubMed · Cited by 183
Post, V., White, P. A., & Hall, R. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq095 · Cited by 178
Holt, K., Kenyon, J. J., Hamidian, M., Schultz, M. B., Pickard, D. J., Dougan, G., & Hall, R. (2016) · Microbial Genomics · doi:10.1099/mgen.0.000052 · Cited by 172
Self-citationWright, M. S., Haft, D. H., Harkins, D. M., Perez, F., Hujer, K. M., Bajaksouzian, S., Benard, M. F., Jacobs, M. R., Bonomo, R. A., & Adams, M. D. (2014) · mBio · doi:10.1128/mbio.00963-13 · Cited by 165
Giannouli, M., Antunes, L. C. S., Marchetti, V., Triassi, M., Visca, P., & Zarrilli, R. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-282 · Cited by 160
Silva, G., & Domingues, S. (2016) · Microorganisms · doi:10.3390/microorganisms4030029 · Cited by 151
Mugnier, P. D., Poirel, L., & Nordmann, P. (2009) · Journal of Bacteriology · doi:10.1128/jb.01258-08 · Cited by 145
Challenges and opportunities for whole‐genome sequencing–based surveillance of antibiotic resistance
Schürch, A. C., & van Schaik, W. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13310 · Cited by 138
Zowawi, H. M., Sartor, A. L., Sidjabat, H. E., Balkhy, H. H., Walsh, T. R., Johani, S. M. A., AlJindan, R. Y., Alfaresi, M. S., Ibrahim, E., Al‐Jardani, A., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02784-14 · Cited by 136
Zhou, H., Zhang, T., Yu, D., Pi, B., Yang, Q., Zhou, J., Hu, S., & Yu, Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01134-10 · Cited by 122
Towner, K. J. (1997) · Journal of Medical Microbiology · doi:10.1099/00222615-46-9-721 · Cited by 121
Ou, H., Kuang, S. N., He, X., Molgora, B. M., Ewing, P. J., Deng, Z., Osby, M., Chen, W., & Xu, H. H. (2015) · Scientific Reports · doi:10.1038/srep08643 · Cited by 119
Zhang, W., Lu, Z., Schwarz, Š., Zhang, R.-M., Wang, X.-M., Si, W., Yu, S., Chen, L., & Liu, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt066 · Cited by 116
Adams, M. D., Chan, E. R., Molyneaux, N., & Bonomo, R. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00057-10 · Cited by 116
Blackwell, G. A., & Hall, R. M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00780-17 · Cited by 113
Fu, Y., Zhou, J., Zhou, H., Yang, Q., Wei, Z., Yu, Y., & Li, L. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq027 · Cited by 112
Hamidian, M., & Hall, R. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr356 · Cited by 111
Self-citationLevy-Blitchtein, S., Roca, I., Plasencia-Rebata, S., Taboada, W. V., Velásquez-Pomar, J., Muñoz, L., Moreno-Morales, J., Pons, M. J., del Valle-Mendoza, J., & Vilà, J. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0127-9 · Cited by 111
Kim, D. H., Choi, J.-Y., Kim, H. W., Ys, K., Chung, D. R., Peck, K. R., Thamlikitkul, V., So, T. M.-K., Yasin, R. M., Hsueh, P., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-13 · Cited by 109
Teerawattanapong, N., Panich, P., Kulpokin, D., Ranong, S. N., Kongpakwattana, K., Saksinanon, A., Goh, B. H., Lee, L., Apisarnthanarak, A., & Chaiyakunapruk, N. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2018.58 · Cited by 107
Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan
Hasan, B., Perveen, K., Olsén, B., & Zahra, R. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.063925-0 · Cited by 100
Evans, B. A., Hamouda, A., Towner, K. J., & Amyes, S. G. B. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01919.x · Cited by 98
Dissemination of Acinetobacter baumannii Clones with OXA-23 Carbapenemase in Colombian Hospitals
Villegas, M. V., Kattán, J. N., Correa, A., Lolans, K., Guzmán, A. M., Woodford, N., Livermore, D. M., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00226-07 · Cited by 93
Transposition of Tn 125 Encoding the NDM-1 Carbapenemase in Acinetobacter baumannii
Bontron, S., Nordmann, P., & Poirel, L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01755-16 · Cited by 89
Repeated local emergence of carbapenem-resistant Acinetobacter baumannii in a single hospital ward
Schultz, M. B., Thanh, D. P., Nhu, T. D. H., Wick, R. R., Ingle, D. J., Hawkey, J., Edwards, D., Kenyon, J. J., Lan, N. P. H., Campbell, J. I., et al. (2016) · Microbial Genomics · doi:10.1099/mgen.0.000050 · Cited by 88
da Silva, K. E., Maciel, W. G., Croda, J., Cayô, R., Ramos, A. C., de Sales, R. O., Kurihara, M. N. L., Vasconcelos, N. G., Gales, A. C., & Simionatto, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209367 · Cited by 79
Brown, S., & Amyes, S. G. B. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01096.x · Cited by 78
Pournaras, S., Dafopoulou, K., Franco, M. D., Zarkotou, O., Dimitroulia, E., Protonotariou, E., Poulou, A., Zarrilli, R., Tsakris, A., Skoura, L., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.01.028 · Cited by 74
Atrouni, A. A., Hamzé, M., Jisr, T., Lemarié, C., Eveillard, M., Joly‐Guillou, M., & Kempf, M. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.09.017 · Cited by 72
Hamidian, M., Kenyon, J. J., Holt, K. E., Pickard, D., & Hall, R. M. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku188 · Cited by 69
Self-citationCameranesi, M. M., Morán-Barrio, J., Limansky, A. S., Repizo, G. D., & Viale, A. M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00066 · Cited by 66
Lee, Y., Kim, C., Lee, H., Jeong, S. H., Yong, D., & Lee, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01672-09 · Cited by 65
Bakour, S., Olaitan, A. O., Ammari, H., Touati, A., Saoudi, S., Saoudi, K., & Rolain, J. (2015) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0214 · Cited by 64
Kumburu, H. H., Sonda, T., van Zwetselaar, M., Leekitcharoenphon, P., Lukjančenko, O., Mmbaga, B. T., Alifrangis, M., Lund, O., Aarestrup, F. M., & Kibiki, G. S. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz055 · Cited by 64
Mussi, M. A., Limansky, A. S., Relling, V. M., Ravasi, P., Arakaki, A. K., Actis, L. A., & Viale, A. M. (2011) · Journal of Bacteriology · doi:10.1128/jb.01533-10 · Cited by 61
Hamidian, M., Hawkey, J., Wick, R. R., Holt, K. E., & Hall, R. M. (2019) · Microbial Genomics · doi:10.1099/mgen.0.000242 · Cited by 60
Self-citationWhole Genome Sequencing—Implications for Infection Prevention and Outbreak Investigations
Popovich, K. J., & Snitkin, E. S. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0570-0 · Cited by 56
AcinetobacterSkin Carriage Among US Army Soldiers Deployed in Iraq
Griffith, M. E., Lazarus, D. R., Mann, P. B., Boger, J. A., Hospenthal, D. R., & Murray, C. K. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/518966 · Cited by 55
Matsui, M., Suzuki, M., Suzuki, M., Yatsuyanagi, J., Watahiki, M., Hiraki, Y., Kawano, F., Tsutsui, A., Shibayama, K., & Suzuki, S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02190-17 · Cited by 48
Ng, D. H. L., Marimuthu, K., Lee, J. J., Khong, W. X., Ng, O. T., Zhang, W., Poh, B. F., Rao, P., Raj, M. D. R., Ang, B. S. P., et al. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0343-z · Cited by 45
Karah, N., Giske, C. G., Sundsfjord, A., & Samuelsen, Ø. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0089 · Cited by 39
Wang, T.-H., Leu, Y., Wang, N., Liu, C.-P., & Yan, T. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0410-5 · Cited by 38
Chen, Y., Yang, Y., Liu, L., Qiu, G.-B., Han, X., Tian, S., Zhao, J., Chen, F., Grundmann, H., Li, H., et al. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3359-3 · Cited by 37
Opazo-Capurro, A., Martín, I. S., Quezada-Aguiluz, M., Morales-León, F., Mariana Domínguez, Y., Lima, C. A., Esposito, F. R. D. S., Cerdeira, L., Bello‐Toledo, H., Lincopán, N., et al. (2019) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2019.04.022 · Cited by 37
Tavares, L. C. B., de Vasconcellos, F. M., de Sousa, W. V., Rocchetti, T. T., Mondelli, A. L., Ferreira, A. M., Montelli, A. C., Sadatsune, T., Tiba‐Casas, M. R., & Camargo, C. H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02898 · Cited by 32
Bannah, A. M. S. E., Nawar, N. N., Hassan, R. M., & Salem, S. T. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0057 · Cited by 29
Mathlouthi, N., Lamine, Y. B., Somai, R., Bouhalila-Besbes, S., Bakour, S., Rolain, J., & Chouchani, C. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0306 · Cited by 28
Jeon, H., Kim, S., Kim, M., Kim, S. Y., Nam, D., Park, S. C., Park, S.-H., Bae, H., Lee, H., Cho, J., et al. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.01.003 · Cited by 26
Alsultan, A. A., Evans, B. A., Aboulmagd, E., Al-Qahtani, A. A., Bohol, M. F. F., Al‐Ahdal, M. N., Opazo-Capurro, A., & Amyes, S. G. B. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00634 · Cited by 25
Lee, Y., Kim, Y. R., Kim, J., Park, Y.-J., Song, W., Shin, J.-H., Uh, Y., Lee, K., Lee, S. H., Cho, J. H., et al. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.06.009 · Cited by 21
Gurung, M., Rho, J. S., Lee, Y. C., Kim, H. S., Moon, S. Y., Yu, B. H., Lee, J., Jang, C. W., Chung, S. Y., Cho, I. H., et al. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.07.016 · Cited by 19
Cheikh, H. B., Domingues, S., Silveira, E., Kadri, Y., Rosário, N., Mastouri, M., & Silva, G. (2018) · 3 Biotech · doi:10.1007/s13205-018-1310-3 · Cited by 18
Kaygısız, A. N. S., Biçmen, M., & Gülay, Z. (2013) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.66.439 · Cited by 17
Huang, L., Sun, L., & Yan, Y. (2013) · The Journal of Microbiology · doi:10.1007/s12275-013-2341-4 · Cited by 16
Antibiotic-resistant clones in Gram-negative pathogens: presence of global clones in Korea
Ko, K. S. (2018) · The Journal of Microbiology · doi:10.1007/s12275-019-8491-2 · Cited by 14
Milan, A., Furlanis, L., Cian, F., Bressan, R., Luzzati, R., Lagatolla, C., Deiana, M. L., Knezevich, A., Tonin, E. A., & Dolzani, L. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0167 · Cited by 12
Tan, T. Y., Poh, K., & Ng, S. Y. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/518964 · Cited by 4
Cited by
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
Miller, W. R., & Arias, C. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01054-w · Cited by 862
Sands, K., Carvalho, M. J., Portal, E., Thomson, K., Dyer, C., Akpulu, C., Andrews, R., Ferreira, A., Gillespie, D., Hender, T., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00870-7 · Cited by 431
Multidrug-resistant Gram-negative bacterial infections
Macesic, N., Uhlemann, A.-C., & Peleg, A. Y. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02081-6 · Cited by 315
Nguyen, M., & Joshi, S. G. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15130 · Cited by 259
Sheldon, J. R., & Skaar, E. P. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008995 · Cited by 177
Metadata
- Authors
- Hamidian, M., & Nigro, S. J.
- Venue
- Microbial Genomics
- Publisher
- Microbiology Society
- Published
- 2019-10-01
- Volume
- 5
- Issue
- 10
- ISSN
- 2057-5858 (ISSN-L)
- OpenAlex
- W2980296480
- Cited by
- 465
- References
- 105
- FWCI
- 11.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.